1. Home
  2. SION vs EMD Comparison

SION vs EMD Comparison

Compare SION & EMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SION
  • EMD
  • Stock Information
  • Founded
  • SION 2019
  • EMD 2003
  • Country
  • SION United States
  • EMD United States
  • Employees
  • SION N/A
  • EMD N/A
  • Industry
  • SION
  • EMD Finance/Investors Services
  • Sector
  • SION
  • EMD Finance
  • Exchange
  • SION NYSE
  • EMD Nasdaq
  • Market Cap
  • SION 338.0M
  • EMD 527.7M
  • IPO Year
  • SION 2025
  • EMD N/A
  • Fundamental
  • Price
  • SION $12.14
  • EMD $9.34
  • Analyst Decision
  • SION Strong Buy
  • EMD
  • Analyst Count
  • SION 1
  • EMD 0
  • Target Price
  • SION $32.00
  • EMD N/A
  • AVG Volume (30 Days)
  • SION 151.8K
  • EMD 248.5K
  • Earning Date
  • SION 05-25-2025
  • EMD 01-01-0001
  • Dividend Yield
  • SION N/A
  • EMD 10.25%
  • EPS Growth
  • SION N/A
  • EMD N/A
  • EPS
  • SION N/A
  • EMD N/A
  • Revenue
  • SION N/A
  • EMD N/A
  • Revenue This Year
  • SION N/A
  • EMD N/A
  • Revenue Next Year
  • SION N/A
  • EMD N/A
  • P/E Ratio
  • SION N/A
  • EMD N/A
  • Revenue Growth
  • SION N/A
  • EMD N/A
  • 52 Week Low
  • SION $7.26
  • EMD $7.85
  • 52 Week High
  • SION $25.19
  • EMD $9.55
  • Technical
  • Relative Strength Index (RSI)
  • SION N/A
  • EMD 50.77
  • Support Level
  • SION N/A
  • EMD $9.00
  • Resistance Level
  • SION N/A
  • EMD $9.12
  • Average True Range (ATR)
  • SION 0.00
  • EMD 0.23
  • MACD
  • SION 0.00
  • EMD 0.05
  • Stochastic Oscillator
  • SION 0.00
  • EMD 97.50

About SION SIONNA THERAPEUTICS INC

Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.

About EMD Western Asset Emerging Markets Debt Fund Inc

Western Asset Emg Markets Debt Fund Inc is a non-diversified closed-end management investment company. Its primary investment objective is to seek high current income and the secondary objective is to seek capital appreciation.

Share on Social Networks: